Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 4/2019

Open Access 01-10-2019 | Sarcopenia | Original Research

The Relationship Between Omega-3, Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs

Authors: Asmaa Abdelhamid, Lee Hooper, Ruksana Sivakaran, Richard P. G. Hayhoe, Ailsa Welch, the PUFAH Group

Published in: Calcified Tissue International | Issue 4/2019

Login to get access

Abstract

We conducted a systematic review and meta-analysis to assess the effects of increasing dietary omega-3, omega-6 and mixed polyunsaturated fatty acids (PUFA) on musculoskeletal health, functional status, sarcopenia and risk of fractures. We searched Medline, Embase, The Cochrane library, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) databases for Randomised Controlled Trials (RCTs) of adults evaluating the effects of higher versus lower oral omega-3, omega-6 or mixed PUFA for ≥ 6 months on musculoskeletal and functional outcomes. We included 28 RCTs (7288 participants, 31 comparisons), 23 reported effects of omega-3, one of omega-6 and four of mixed total PUFA. Participants and doses were heterogeneous. Six omega-3 trials were judged at low summary risk of bias. We found low-quality evidence that increasing omega-3 increased lumbar spine BMD by 2.6% (0.03 g/cm2, 95% CI − 0.02 to 0.07, 463 participants). There was also the suggestion of an increase in femoral neck BMD (of 4.1%), but the evidence was of very low quality. There may be little or no effect of omega-3 on functional outcomes and bone mass; effects on other outcomes were unclear. Only one study reported on effects of omega-6 with very limited data. Increasing total PUFA had little or no effect on BMD or indices of fat-free (skeletal) muscle mass (low-quality evidence); no data were available on fractures, BMD or functional status and data on bone turnover markers were limited. Trials assessing effects of increasing omega-3, omega-6 and total PUFA on functional status, bone and skeletal muscle strength are limited with data lacking or of low quality. Whilst there is an indication that omega-3 may improve BMD, high-quality RCTs are needed to confirm this and effects on other musculoskeletal outcomes.
Appendix
Available only for authorised users
Literature
1.
Gillette-Guyonnet S, Nourhashemi F, Lauque S, Grandjean H, Vellas B (2000) Body composition and osteoporosis in elderly women. Gerontology 46:189–193CrossRefPubMed
2.
Iannuzzi-Sucich M, Prestwood KM, Kenny AM (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Ser A 57:M772–777CrossRef
3.
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Iorio AD, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860CrossRefPubMed
4.
Fried LP, Guralnik JM (1997) Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 45:92–100CrossRefPubMed
5.
Hunter DJ, Sambrook PN (2000) Bone loss: epidemiology of bone loss. Arthritis Res Ther 2:441–445CrossRef
6.
Metter EJ, Conwit R, Tobin J, Fozard JL (1997) Age-associated loss of power and strength in the upper extremities in women and men. J Gerontol Ser A 52:B267–276CrossRef
7.
Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136CrossRefPubMedPubMedCentral
8.
Sousa AS, Guerra RS, Fonseca I, Pichel F, Ferreira S, Amaral TF (2016) Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr 70:1046–1051CrossRefPubMed
9.
Ethgen O, Beaudart C, Buckinx F, Bruyere O, Reginster JY (2016) The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 100:229–234CrossRefPubMedPubMedCentral
10.
United Nations Department of Economic Social Affairs (2017) World population prospects: The 2017 revision, key findings and advance tables. Working Paper No. ESA/P/WP/248, Accessed 2017
11.
Melzer K (2011) Carbohydrate and fat utilization during rest and physical activity. e-SPEN 6:45–52CrossRef
12.
Lipina C, Hundal HS (2017) Lipid modulation of skeletal muscle mass and function. J Cachexia Sarcopenia Muscle 8:190–201CrossRefPubMed
13.
Mangano KM, Sahni S, Kerstetter JE, Kenny AM, Hannan MT (2013) Polyunsaturated fatty acids and their relation with bone and muscle health in adults. Curr Osteoporos Rep 11:203–212CrossRefPubMed
14.
Tachtsis B, Camera D, Lacham-Kaplan O (2018) Potential roles of n-3 PUFAs during skeletal muscle growth and regeneration. Nutrients 10:309CrossRefPubMedCentral
15.
Maurin AC, Chavassieux PM, Meunier PJ (2005) Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. Calcif Tissue Int 76:385–392CrossRefPubMed
16.
Haag M, Magada ON, Claassen N, Bohmer LH, Kruger MC (2003) Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption. Prostaglandins Leukot Essent Fatty Acids 68:423–429CrossRefPubMed
17.
Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK (2013) Low fat diet with omega-3 fatty acids increases plasma insulin-like growth factor concentration in healthy postmenopausal women(1). Nutr Res 33:565–571CrossRefPubMedPubMedCentral
18.
Paunescu A-C, Dewailly É, Dodin S, Nieboer E, Ayotte P (2013) Dioxin-like compounds and bone quality in Cree women of Eastern James Bay (Canada): a cross-sectional study. Environmental Health 12:54CrossRefPubMedPubMedCentral
19.
Shen D, Zhang X, Li Z, Bai H, Chen L (2017) Effects of omega-3 fatty acids on bone turnover markers in postmenopausal women: systematic review and meta-analysis. Climacteric: the journal of the International Menopause Society 20:522–527CrossRef
20.
21.
Buoite Stella A, Gortan Cappellari G, Barazzoni R, Zanetti M (2018) Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review. International journal of molecular sciences 19
22.
Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M (2010) The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr) 32:179–186CrossRef
23.
24.
Albertazzi P, Coupland K (2002) Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 42:13–22CrossRefPubMed
25.
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedPubMedCentral
26.
27.
28.
29.
Brown TJ, Brainard JS, Song F, Wang X, Abdelhamid A, Hooper L, PUFAH Group (2019) Omega-3, omega-6 and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Br Med J
30.
Deane KHO, Jimoh OF, Biswas P, O’Brien AT, Hanson S, Abdelhamid A, Fox C, Hooper L (2019) Omega-3, omega-6 and total polyunsaturated fat for prevention of depression and anxiety symptoms: a systematic review and meta-analysis of randomised trials. Submitted
31.
Hanson S, Thorpe G, Winstanley L, Abdelhamid A, Hooper L (2017) Effects of supplementary dietary polyunsaturated fat on cancer incidence. PROSPERO:CRD42017056109
32.
33.
Brainard J, Jimoh OF, Deane K, Biswas P, Donaldson D, Maas K, Abdelhamid A, Hooper L (2019) Omega-3, omega-6 and total polyunsaturated fat for cognition and dementia: systematic review and meta-analysis of RCTs
34.
Thorpe G, Ajabnoor S, Ahmed Z, Abdelhamid A, Hooper L (2017) Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease. PROSPERO:CRD42017068704
35.
Hooper L, Abdelhamid A, Brainard J, Deane KHO, Song F, Group P (2019) Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews. BMJ Open 9:e029554CrossRefPubMedPubMedCentral
36.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Br Med J 343:d5928CrossRef
37.
Welch AA, Skinner J, Hickson M (2017) Dietary magnesium may be protective for aging of bone and skeletal muscle in middle and younger older age men and women: cross-sectional findings from the UK Biobank cohort. Nutrients 9:E1189CrossRefPubMed
38.
Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 83:629–635CrossRefPubMed
39.
Baxheinrich A, Stratmann B, Lee-Barkey Y, Tschoepe D, Wahrburg U (2012) Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of alpha-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr 108:682–691CrossRefPubMed
40.
Dodin S, Lemay A, Jacques H, Legare F, Forest JC, Masse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90:1390–1397CrossRefPubMed
41.
Dong H, Hutchins-Wiese H, Kleppinger A, Annis K, Liva E, Lammi-Keefe C, Durham H, Feinn R, Kenny AM (2014) Effects of omega-3 polyunsaturated fatty acid supplementation on bone turnover in older women. Int J Vitam Nutr Res 84:124–132CrossRefPubMed
42.
Hutchins-Wiese HL, Kleppinger A, Annis K, Liva E, Lammi-Keefe CJ, Durham HA et al (2013) The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidants on physical performance in postmenopausal women. J Nutr Health Aging 17:76–80CrossRefPubMed
43.
Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH (1998) Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milan, Italy) 10:385–394
44.
Tardivo AP, Nahas-Neto J, Orsatti CL, Dias FB, Poloni PF, Schmitt EB, Nahas EA (2015) Effects of omega-3 on metabolic markers in postmenopausal women with metabolic syndrome. Climacteric 18:290–298CrossRefPubMed
45.
Tartibian B, Hajizadeh Maleki B, Kanaley J, Sadeghi K (2011) Long-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures study. Nutr Metab 8:71–71CrossRef
46.
Vanlint SJ, Ried K (2012) Efficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCT. Maturitas 71:44–48CrossRefPubMed
47.
Bullo M, Amigo-Correig P, Marquez-Sandoval F, Babio N, Martinez-Gonzalez MA, Estruch R, Basora J, Sola R, Salas-Salvado J (2009) Mediterranean diet and high dietary acid load associated with mixed nuts: effect on bone metabolism in elderly subjects. J Am Geriatr Soc 57:1789–1798CrossRefPubMed
48.
Fernandez-Real JM, Bullo M, Moreno-Navarrete JM, Ricart W, Ros E, Estruch R et al (2012) A Mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J Clin Endocrinol Metab 97:3792–3798CrossRefPubMedPubMedCentral
49.
Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI et al (1993) Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care 16:8–15CrossRefPubMed
50.
Alvarez-Perez J, Sanchez-Villegas A, Diaz-Benitez EM, Ruano-Rodriguez C, Corella D, Martinez-Gonzalez MA, Estruch R, Salas-Salvado J, Serra-Majem L, Investigators PS (2016) Influence of a mediterranean dietary pattern on body fat distribution: results of the PREDIMED-canarias intervention randomized trial. J Am Coll Nutr 35:1–13CrossRef
51.
Stammers T, Sibbald B, Freeling P (1992) Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice. Ann Rheum Dis 51:128–129CrossRefPubMedPubMedCentral
52.
Danthiir V, Hosking D, Burns NR, Wilson C, Nettelbeck T, Calvaresi E et al (2014) Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. J Nutr 144:311–320CrossRefPubMed
53.
Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PR (2012) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 107:1682–1693CrossRefPubMed
54.
Faxén Irving G, Freund-Levi Y, Eriksdotter-Jönhagen M, Basun H, Brismar K, Hjorth E, Palmblad J, Vessby B, Vedin I, Wahlund L, Cederholm T (2009) N-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer’s disease: the OmegAD Study. J Am Geriatr Soc 57:11–17CrossRef
55.
Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S et al (2017) Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol 16:377–389CrossRefPubMed
56.
Galan P, Briancon S, Blacher J, Czernichow S, Hercberg S (2008) The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics. Trials 9:35–35CrossRefPubMedPubMedCentral
57.
Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S, Group SFOC (2010) Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 341:c6273CrossRef
58.
Gruenwald J, Petzold E, Busch R, Petzold HP, Graubaum HJ (2009) Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis. Adv Ther 26:858–871CrossRefPubMed
59.
Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K et al (2016) Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Ann Rheum Dis 75:23–29CrossRefPubMed
60.
Dasarathy S, Dasarathy J, Khiyami A, Yerian L, Hawkins C, Sargent R, McCullough A (2015) Double blind randomized placebo controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 49:137–144CrossRefPubMedPubMedCentral
61.
Järvinen R, Tuppurainen M, Erkkilä AT, Penttinen P, Kärkkäinen M, Salovaara K, Jurvelin JS, Kröger H (2011) Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women. Eur J Clin Nutr 66:496CrossRefPubMed
62.
63.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRef
64.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older P, the Extended Group for E (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31CrossRef
65.
Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM et al (2012) Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 96:748–758CrossRefPubMedPubMedCentral
66.
Walker CG, Browning LM, Stecher L, West AL, Madden J, Jebb SA, Calder PC (2015) Fatty acid profile of plasma NEFA does not reflect adipose tissue fatty acid profile. Br J Nutr 114:756–762CrossRefPubMed
67.
Welch AA, Shakya-Shrestha S, Lentjes MA, Wareham NJ, Khaw KT (2010) Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J Clin Nutr 92:1040–1051CrossRefPubMed
68.
Clark LF, Thivierge MC, Kidd CA, McGeoch SC, Abraham P, Pearson DW, Horgan GW, Holtrop G, Thies F, Lobley GE (2016) Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial. Br J Nutr 115:75–86CrossRefPubMed
69.
Danthiir V, Burns NR, Nettelbeck T, Wilson C, Wittert G (2011) The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr J 10:117–117CrossRefPubMedPubMedCentral
70.
Chen JS, Hill CL, Lester S, Ruediger CD, Battersby R, Jones G, Cleland LG, March LM (2016) Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial. Osteoporos Int 27:1897–1905CrossRefPubMed
71.
Van De Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, De Groot CP (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71:430–438CrossRefPubMed
72.
Norouzi Javidan A, Sabour H, Latifi S, Abrishamkar M, Soltani Z, Shidfar F, Emami Razavi H (2014) Does consumption of polyunsaturated fatty acids influence on neurorehabilitation in traumatic spinal cord-injured individuals? A double-blinded clinical trial. Spinal Cord 52:378–382CrossRefPubMed
73.
Garbagnati F, Cairella G, De Martino A, Multari M, Scognamiglio U, Venturiero V et al (2009) Is antioxidant and n-3 supplementation able to improve functional status in poststroke patients? Results from the Nutristroke Trial. Cerebrovasc Dis 27:375–383CrossRefPubMed
74.
Freund Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén Irving G, Garlind A, VedinI Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment of 174 patients with mild to moderate Alzheimer’s disease (OmegAD): a randomized double-blind trial. Arch Neurol 63:1402–1408CrossRefPubMed
75.
Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B (2015) Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 102:115–122CrossRefPubMedPubMedCentral
76.
Wang F, Wang Y, Zhu Y, Liu X, Xia H, Yang X (2016) Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial. Eur J Nutr 1:1. https://​doi.​org/​10.​1007/​s00394-016-1352-4 CrossRef
77.
Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L et al (2014) Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the WELCOME study. Hepatology 60:1211–1221CrossRefPubMed
78.
Estruch R, Ros E, Salas-Salvadó J, Covas M, Corella D, Arós F et al (2018) Retraction and republication: primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013 368:1279–1290
Metadata
Title
The Relationship Between Omega-3, Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs
Authors
Asmaa Abdelhamid
Lee Hooper
Ruksana Sivakaran
Richard P. G. Hayhoe
Ailsa Welch
the PUFAH Group
Publication date
01-10-2019
Publisher
Springer US
Keyword
Sarcopenia
Published in
Calcified Tissue International / Issue 4/2019
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00584-3

Other articles of this Issue 4/2019

Calcified Tissue International 4/2019 Go to the issue

Original Research

Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy

Review

Role of Nrf2 in Fracture Healing: Clinical Aspects of Oxidative Stress

Original Research

Vitamin D Status in Paget Disease of Bone and Efficacy–Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D

Original Research

The Local and Systemic Interactions Between Muscle and Bone in Postmenopausal Korean Women

Original Research

Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis via NADPH Oxidase-Interleukin 1β and 6 Pathway in Osteocyte-like Cells

Original Research

Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits